Editas Medicine (EDIT) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

EDIT is expected to report earnings to fall 5.09% to -77 cents per share on November 06

Editas Medicine EDIT Stock Earnings Reports

Q3'24

Est.

$-0.78

Q2'24

Missed

by $0.12

Q1'24

Missed

by $0.13

Q4'23

Beat

by $0.36

Q3'23

Beat

by $0.03

The last earnings report on August 07 showed earnings per share of -81 cents, missing the estimate of -69 cents. With 2.06M shares outstanding, the current market capitalization sits at 287.02M.

View a ticker or compare two or three

Compare

EDIT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EDIT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for EDIT (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

11 Hurley Street

Phone

+1 617 401-9000

Employees

265

Web

https://www.editasmedicine.com